Oasis Management Company’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History

Oasis Management Company’s Portfolio EFTR Stock Details EFTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-4,000	Closed	-$1.17M	–	82
2023 Q4	$1.17M	Hold	4,000	–	–	0.22%	27
2023 Q3	$60K	Hold	4,000	–	–	﹤0.01%	62
2023 Q2	$83K	Hold	4,000	–	–	0.02%	64
2023 Q1	$35.3K	Hold	4,000	–	–	0.01%	70
2022 Q4	$42.8K	Hold	4,000	–	–	0.01%	105
2022 Q3	$57K	Hold	4,000	–	–	0.01%	129
2022 Q2	$142K	Hold	4,000	–	–	0.03%	118
2022 Q1	$401K	Buy	+4,000	New	+$532K	0.06%	74

Other funds holding EFTR

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Ensign Peak Advisors

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return